Occidental Petroleum
OXY
DaVita
DVA
Citigroup
C
Chubb Ltd
CB
Chevron
CVX
US Stock MarketDetailed Quotes
RVNC Revance Therapeutics
- 3.290
- +0.040+1.23%
Close Jan 13 16:00 ET
- 3.290
- 0.0000.00%
Post 16:20 ET
343.44MMarket Cap-1.71P/E (TTM)
3.360High3.260Low2.26MVolume3.310Open3.250Pre Close7.46MTurnover2.36%Turnover RatioLossP/E (Static)104.39MShares7.56052wk High-2.11P/B315.61MFloat Cap2.30052wk Low--Dividend TTM95.93MShs Float42.410Historical High--Div YieldTTM3.08%Amplitude2.300Historical Low3.295Avg Price1Lot Size
Revance Therapeutics Stock Analyst Ratings & Price Target
Price Target
Updated: Jan 13, 2025
The average Revance Therapeutics stock price target is 6.75 with a max estimate of 7.00 and a min estimate of 6.60
Review Revance Therapeutics earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Trending US Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Analysis
Price Target
Updated: Jan 13, 2025